Drug Abuse | academiascholars.com

QUESTION

Drug Abuse

Annotated Bibliography Template: Citation: (APA format) Author, A. A., Author, B. B., & Author, C. C. (Year). Title of article. Title of Periodical, volume number(issue number), pages. https://doi.org/xx.xxx/yyyy

Annotation: (Use the “Who, What, When, Where, Why and How” (4Ws & H) method for each annotation. Each annotation should be 80 – 150 words long.)

Citation: (APA format) Author, A. A., Author, B. B., & Author, C. C. (Year). Title of article. Title of Periodical, volume number(issue number), pages. https://doi.org/xx.xxx/yyyy

Annotation: (Use the “Who, What, When, Where, Why and How” (4Ws & H) method for each annotation. Each annotation should be 80 – 150 words long.)

Citation: (APA format) Author, A. A., Author, B. B., & Author, C. C. (Year). Title of article. Title of Periodical, volume number(issue number), pages. https://doi.org/xx.xxx/yyyy

Annotation: (Use the “Who, What, When, Where, Why and How” (4Ws & H) method for each annotation. Each annotation should be 80 – 150 words long.)

Types of Literature:
- Peer Review Literature:articles that meet the quality standards established for a given discipline, are reviewed by individuals specialized in the same scholarly area as the author, and exemplify the best research practices in a field.
- Grey Literature:materials and research produced by organizations outside of the academic publishing and often include reports and articles produced by governmental agencies and departments, civil societies and non-governmental organizations
Assignment Instructions:

Health care in the United States is provided by a multitude of services including government-funded agencies.
1. Select a federally funded health care agency from the list below:
2. Now create an annotated bibliography (80 – 150 words) for each of the following source/article for a total of 3 annotated bibliographies.
#1 Annotated Bibliography: Review the agency’s website and obtain information describing the purpose of the agency and the population served.

#2 Annotated Bibliography: From the agency’s website discuss 1current research project or initiative being conducted by the agency.

#3 Annotated Bibliography: Search for a scholarly, peer review article within the Excelsior Library that discusses the importance of this research to the community.

Using the 4Ws and H approach for each annotation write a concise annotation that summarizes the central theme and scope of the source/article while addressing the following:
- What is the purpose of the article
- Who is the intended audience the work is written for
- Why is it relevance to the topic
- When was it conducted or completed
- Where there any special or unique features about the material
- How was it complied?
Resources:
- Example of Annotated Bibliography: Amyloid Research
- Citation: Adams, D., Suhr, O. B., Dyck, P. J., Litchy, W. J., Leahy, R. G., Jihong Chen, … Chen, J. (2017). Trial design and rationale for APOLLO, a Phase 3, placebo-controlled study of patisiran in patients with hereditary ATTR amyloidosis with polyneuropathy. BMC Neurology, 17, 1–12. https://doi.org/10.1186/s12883-017-0948-5
- Annotation: In a randomized, double-blind, placebo-controlled, global study researchers evaluate the efficacy and safety of the drug Patisiran in patients with hATTR amyloidosis with polyneuropathy. Hereditary ATTR (hATTR),a progressive, life-threatening disease, is caused by mutant protein that accumulate as amyloid fibrils in multiple organs, including the nerves, heart, and gastrointestinal tract. The accumulation of these fibrils ultimately results in total breakdown of the organ. Patients were recruited from 46 sites across 19 countries. The results of the study, funded by multiple sources, is the largest such study to date addressing possible treatment of hATTR amyloidosis. The study is ongoing and has already provided significant insight into how various treatments are impacting this disease.

Subject	Drug Abuse	Pages	2	Style	APA

Answer

1. Drug Abuse: Annotated Bibliography
  
  Citation: National Institute on Drug Abuse. (2020). National institute on drug abuse: Advancing addiction science. https://www.drugabuse.gov/
  
  Annotation: National Institute on Drug Abuse (NIDA) is the leading federal agency that supports scientific research on drug use as well as its consequences. NIDA supports research on a wide array of prevention and treatment interventions that benefits the general population, across different age groups. Different topics on drugs of abuse, which are of interest to NIDA, include opioids, pain medications, prescription drugs, heroin, fentanyl, tobacco, illicit opioids, brain and addiction, marijuana, cocaine, drug overdoses in youth, sedatives, kratom, inhalants, over-the-counter medications, illegal drugs, prescription stimulants, alcohol, naloxone, and nicotine. The organization also provides grants and funding as well as resources to support research initiatives on depending on research priorities in a given time.
  
  Citation: The BRAIN Initiative. (2020). The BRAIN initiative. https://braininitiative.nih.gov/about/overview
  
  Annotation: The Brain Research trough Advancing Innovative Neurotechnologies (BRAIN) Initiative aims to develop better understanding of the human brain and how it functions both in health and disease. The underlying causes of most psychiatric and neurological conditions remain largely unknown. This is because the human brain remains one of the major mysteries of science. High resolution technologies will be used to observe how the brain is functionally and structurally connected in living humans. National Institute of Health has established a high-level working-group of the Advisory Committee to the National Institute of Health Director so as to help shape this new initiative. Input from broad range of stakeholders and interest groups including the public, the scientific community, and patient advocates have been sought and taken into consideration. The report titled ‘BRAIN 2025: A Scientific Vision’ was released in Jun 2014 and was subsequently endorsed by the Advisory Committee to the National Institute of Health Director. The report articulates the scientific goals of the Initiative and a multi-year scientific plan for realizing these goals, including milestones, timetables, and cost estimates.
  
  Citation: Ramos, K. M., Rommelfanger, K. S., Greely, H. T., & Koroshetz, W. J. (2018). Nueroethics and the NIH BRAIN Initiative. J Responsible Innov., 5(1), 122-130. https://dx.doi.org/10.1080%2F23299460.2017.1319035
  
  Annotation: The purpose of the study was to discuss the BRAIN Initiative as well as its aspirations and implications to neuroethics. The authors also discussed new opportunities for integrating stakeholder voices and for collaboration. The BRAIN Initiative will revolutionize the understanding of the scientific community as well as that of the public on how the brain functions in disease and health. It can have a significant impact in addressing the growing societal impact of mental health, neurological, and substance abuse disorders. New advances in neurotechnology can provide new ways for modulating and interrogating brain functions. Neuroethics Division of the National Institute of Health BRAIN Initiative Multi-Council Working Group has been established so as to help the BRAIN Initiative to navigate through issues involving ethics. Collaboration and multi-agency involvement in the BRAIN Initiative provides the best chance of delivering on the promise of scientific-advances so as to treat and prevent disorders and diseases of the brain.